FT : Former Yandex AI group raises $700mn from investors including Nvidia

Former Yandex AI group raises $700mn from investors including Nvidia
Nebius, led by Russian-Israeli billionaire Arkady Volozh, believes deal will help ‘neocloud’ group return from ‘the ashes’

Nebius, the artificial intelligence infrastructure group that was formed from Yandex’s operations outside Russia earlier this year, has raised $700mn from investors including chipmaker Nvidia to capitalise on exploding demand for AI data centres.

The new equity financing, via a private placement, comes six weeks after trading in Nebius’ stock resumed on Nasdaq, following its split in July from Yandex, Russia’s biggest internet group. Other investors involved in the deal announced on Monday include Silicon Valley venture firm Accel.

Nebius, led by chief Arkady Volozh, a rare Russian businessman to publicly condemn Moscow’s invasion of Ukraine and who has become an Israeli citizen, said: “Now we are finalising our journey from the ashes back in July to being a real company with real capital.”

Nvidia’s move to take a stake displayed the “very good and deep relationship” between Nebius and the dominant supplier of AI chips, Volozh said. The company plans to bring Nvidia’s new Blackwell series of graphics processing units online in its cloud service next year.

“Of course we hope that such a close relationship will help us to get more quotas [of Nvidia chips] and sooner,” Volozh added. “It [Nvidia’s equity investment] doesn’t have a direct relationship to getting the GPUs, the deal is not about the GPUs. But of course it shows our close relationship which we hope will influence our pipelines.”

Two years after the launch of OpenAI’s ChatGPT kick-started a wave of investment in AI infrastructure, demand for computing capacity to train ever-larger models shows few signs of slowing. Nvidia has said it expects demand to exceed supply of Blackwell for most of next year.

Amsterdam-headquartered Nebius is racing to build out new data centres packed with Nvidia’s chips to train and run AI systems for clients including French AI group Mistral. It is competing with other so-called AI “neocloud” services such as Nvidia-backed CoreWeave, which has raised more than $9bn in equity and debt to date according to PitchBook, as well as its US rivals Lambda Labs and Crusoe.

By focusing on new ways of building data centres that they say are better suited to the requirements of AI, neocloud companies are trying to challenge the dominance of Amazon Web Services, Microsoft’s Azure and Google Cloud in the cloud computing market.

Nebius’ biggest data centre is in Mäntsälä, Finland but Volozh told reporters on Monday that the new capital would finance its plans to expand in the US next year, where demand from customers is stronger than in Europe.

“This is not the last capital we will be raising,” Volozh said, suggesting it could return to the market later next year. “But we are one of only a few public companies [among AI neoclouds] which provides us cheaper access to capital . . . I think we are one of the few or the only one in this new cloud push who has no debt.”

Shares in US-listed Yandex were suspended in 2022 following Russia’s full-scale invasion of Ukraine. After a protracted negotiation with the Kremlin, Yandex struck a $5.4bn deal in February to sell its core Russian business to a consortium of investors.

Nebius is formed from the remainder of Yandex’s former international operations. As well as its main focus on AI cloud computing, the group also includes a self-driving car venture, Avride, and an edtech service.

At the same time as announcing the new funds, Nebius said it would cancel a planned share buyback, pointing to high volumes since trading resumed on Nasdaq that would have allowed any investors from the Yandex era to exit the stock if they wished to.

Following the equity financing Nebius will have more than $3bn in cash. The company said it expects its annual revenue run rate to grow to $750mn-$1bn by the end of next year, up from previous guidance of $500mn-$1bn.

>>> US Research Calls II

Research Calls II
  • Upgrades:
    • Akamai Tech (AKAM) upgraded to Outperform from Perform at Oppenheimer; tgt $120
    • Fastly (FSLY) upgraded to Outperform from Perform at Oppenheimer; tgt $12
    • Gap (GAP) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $30
    • Tesla (TSLA) upgraded to Buy from Neutral at ROTH MKM; tgt raised to $380
  • Downgrades:
    • Applied Therapeutics (APLT) downgraded to Neutral from Buy at UBS; tgt lowered to $2
    • Nu Holdings (NU) downgraded to Sell from Neutral at Citigroup; tgt lowered to $11
  • Others:
    • Apple (AAPL) reiterated with a Neutral at UBS; tgt $236
    • Cleveland-Cliffs (CLF) initiated with a Buy at Goldman; tgt $16
    • Commercial Metals (CMC) initiated with a Buy at Goldman; tgt $75
    • Integra (IART) initiated with an Underweight at Morgan Stanley; tgt lowered to $20
    • Nucor (NUE) initiated with a Buy at Goldman; tgt $190
    • Radius Recycling (RDUS) initiated with a Neutral at Goldman; tgt $22
    • Reliance, Inc. (RS) initiated with a Neutral at Goldman; tgt $341
    • Soleno Therapeutics (SLNO) reiterated with an Outperform at Robert W. Baird; tgt $72
    • Steel Dynamics (STLD) initiated with a Neutral at Goldman; tgt $155

>>> MicroStrategy reports bitcoin holding and ATM updates; From October 1, 2024

MicroStrategy reports bitcoin holding and ATM updates; From October 1, 2024 to December 1, 2024, the Company’s BTC Yield was 38.7%
  • ATM Update: As previously disclosed, on October 30, 2024, MicroStrategy entered into a Sales Agreement, pursuant to which the Company may issue and sell shares of its class A common stock, par value $0.001 per share ("Shares"), having an aggregate offering price of up to $21 billion from time to time through the Sales Agents. On December 2, 2024, the Company announced that, during the period between November 25, 2024 and December 1, 2024, the Company had sold an aggregate of 3,728,507 Shares under the Sales Agreement for aggregate net proceeds to the Company (less sales commissions) of approximately $1.48 billion. As of December 1, 2024, approximately $11.3 billion of Shares remained available for issuance and sale pursuant to the Sales Agreement.
  • Bitcoin Holdings Update: On December 2, 2024, the Company announced that, during the period between November 25, 2024 and December 1, 2024, the Company acquired approximately 15,400 bitcoins for approximately $1.5 billion in cash, at an average price of approximately $95,976 per bitcoin, inclusive of fees and expenses. The bitcoin purchases were made using proceeds from the issuance and sale of Shares under the Sales Agreement. As of December 1, 2024, the Company, together with its subsidiaries, held an aggregate of approximately 402,100 bitcoins, which were acquired at an aggregate purchase price of approximately $23.4 billion and an average purchase price of approximately $58,263 per bitcoin, inclusive of fees and expenses.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • PCG -2.2% (also announces launch of concurrent offerings of common stock and mandatory convertible preferred stock), BWLP -2.1%
Other news:
  • NVCR -12.8% (topline results from Phase 3 PANOVA-3 clinical trial of tumor treating fields therapy for pancreatic cancer)
  • MLCO -9.3% (Macau revs)
  • STLA -8.6% (CEO resigns)
  • HAFN -3.2% (launches share buy-back program)
  • LI -3.2% (November deliveries)
  • CORZ -3% (announces proposed convertible senior notes offering)
  • IREN -1.2% (increased its installed self-mining capacity by 33% to 28 EH/s; On-track for 31 EH/s this month)
  • THS -1.1% (acquisition of Harris Tea for approximately $205 million; reaffirms FY24 guidance)
  • LSPD -1.1% (commences strategic reorganization; reaffirms FY25 outlook)
  • MARA -1% (bitcoin production and mining operation updates for November 2024)
  • BITF -0.9% (November 2024 production and operations update)

>>> US Gapping up

Gapping up
News:
  • PPBT +61.8% (final results from the randomized Phase 2 study of its lead oncology drug, CM24)
  • PTCT +18.5% (Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program)
  • NBIS +17.7% (entered into definitive agreements for a $700 million private placement financing)
  • OLMA +13% (new clinical trial collaboration and supply agreement with Novartis in frontline metastatic breast cancer)
  • RDHL +11.6% (awarded a judgment of approximately $8 million plus costs in a summary judgment by the New York Supreme Court in its legal proceedings against Kukbo Co)
  • MRUS +6.8% (Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024)
  • SMHI +4.8% (announces complete debt refinancing, newbuild orders, and vessel sales)
  • XPEV +4.1% (November deliveries)
  • AITR +3.2% (terminates business combination agreement with American Metals LLC)
  • ZK +2.9% (November deliveries)
  • API +2.9% (enters voluntary lock-ups by senior management)
  • AUTL +2.4% (publication of data from the FELIX study of obe-cel in r/r Adult B-ALL patients in The New England Journal of Medicine)
  • IHS +0.9% (signs agreement to sell Kuwait Operations to Zain Group)
  • WYNN +0.8% (Macau revs)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Ares Capital (ARCC) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $23
    • Embecta Corp. (EMBC) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $20
    • Globus Medical (GMED) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $100
    • Intuitive Surgical (ISRG) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $650
    • LVMH (LVMUY) upgraded to Buy from Hold at HSBC Securities
    • NovoCure (NVCR) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $30
    • Paycor (PYCR) upgraded to Buy from Hold at TD Cowen; tgt raised to $22
    • Stryker (SYK) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $445
    • Tandem Diabetes Care (TNDM) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $45
  • Downgrades:
    • AnaptysBio (ANAB) downgraded to Neutral from Buy at BTIG Research
    • Bausch + Lomb (BLCO) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt $19
    • Blackstone Secured Lending Fund (BXSL) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $29
    • Glaukos (GKOS) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt $120
    • Kering SA (PPRUY) downgraded to Underweight from Neutral at JP Morgan
    • Kohl's (KSS) downgraded to Neutral from Buy at Guggenheim
    • Markel Group (MKL) downgraded to Hold from Buy at TD Cowen; tgt lowered to $1836
    • Nevro (NVRO) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $4
  • Others:
    • Block (SQ) named new best idea for 2025 at Bernstein; tgt raised to $120
    • BrightView (BV) initiated with a Buy at BTIG Research; tgt $22
    • Dominion Energy (D) resumed with a Equal-Weight at Morgan Stanley; tgt $61
    • Elanco Animal Health (ELAN) initiated with a Market Perform at Leerink Partners; tgt $14
    • IDEXX Labs (IDXX) initiated with a Outperform at Leerink Partners; tgt $500
    • PROCEPT BioRobotics (PRCT) initiated with a Overweight at Morgan Stanley; tgt $105
    • Voyager Therapeutics (VYGR) initiated with a Buy at Citigroup; tgt $12
    • Zoetis (ZTS) initiated with a Outperform at Leerink Partners; tgt $215

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • MRUS +7.2%, API +5.4%, XPEV +4.3%, AITR +3.2%, ZK +3%, IHS +1.5%, LVS +1%, WYNN +0.7%, GEHC +0.6%, EC +0.6%, FANG +0.5%, DIS +0.5%
  • Gapping down:
    • MLCO -9.3%, STLA -8.6%, CORZ -5.5%, LI -3.7%, HAFN -3%, BWLP -3%, IREN -2%, APGE -1.6%, KEYS -1.5%, NVDA -1.3%, WRD -1%, ARM -0.7%, INTC -0.6%

>>> Europe : Brokers Upgrades & Downgrades - 2nd of December 2024 V3(++)

>>> Up
* AB Foods Raised to Hold at Deutsche Bank (+)
* Air Liquide Raised to Overweight at JPMorgan; PT 195 euros
* Akzo Nobel Raised to Overweight at JPMorgan; PT 70 euros
* Anglo American PT Raised to 3,000 pence from 2,800 pence at UBS (++)
* Barratt Redrow PLC Raised to Outperform at RBC
* BASF Raised to Buy at Deutsche Bank (+)
* Burberry Raised to Buy at Deutsche Bank (+)
* CMC Markets Raised to Hold at Jefferies; PT 275 pence
* Crest Nicholson Raised to Sector Perform at RBC
* Endesa Raised to Outperform at RBC; PT 24 euros
* Enel Raised to Outperform at BNPP Exane (+)
* Fresenius Medical Care Raised to Neutral at BofA (+)
* Grenergy Renovables Raised to Buy at CaixaBank BPI; PT 45 euros (++)
* Hermes Raised to Buy at HSBC; PT 2,500 euros
* Howden Joinery Raised to Buy at Panmure Liberum; PT 965 pence (+)
* IMCD Raised to Hold at Deutsche Bank (+)
* Inditex Raised to Hold at Deutsche Bank (+)
* Johnson Matthey Raised to Neutral at JPMorgan; PT 1,600 pence
* Johnson Matthey PT Raised to 2,400 pence at Panmure Liberum (++)
* KBC Raised to Outperform at KBW; PT 85 euros
* LVMH Raised to Buy at HSBC; PT 727 euros
* MTU Aero PT Raised to 405 euros from 390 euros at JPMorgan
* Nexstim Raised to Accumulate at Inderes; PT 6.20 euros (++)
* Nike PT Cut to $73 from $77 at JPMorgan (+)
* Novo Raised to Outperform at BNPP Exane; PT 930 kroner
* Philips ADRs Raised to Hold at Jefferies; PT $26.40
* Redeia Raised to Outperform at BNPP Exane (+)
* Rockwool Raised to Buy at Danske Bank Markets; PT 3,100 kroner (++)
* Syensqo Raised to Buy at Deutsche Bank (+)
* Wood Raised to Equal-Weight at Barclays; PT 75 pence
* Zegna Group Raised to Neutral at BNPP Exane; PT $7.90

>>> Down
* EDP Renovaveis Cut to Underperform at BNPP Exane (+)
* Hexicon Cut to Sell at Inderes; PT 0.14 kronor (+)
* Iberdrola Cut to Sector Perform at RBC
* K+S Cut to Sell at Deutsche Bank (+)
* Kering Cut to Underweight at JPMorgan; PT 195 euros
* MJ Gleeson Cut to Sector Perform at RBC
* Orsted Cut to Underperform at BNPP Exane (+)
* OVH Cut to Sell at Stifel; PT 7 euros
* Persimmon Cut to Underperform at RBC
* Progyny Cut to Neutral at JPMorgan; PT $17
* Sandoz Group Cut to Neutral at BNPP Exane; PT 41 Swiss francs
* Severfield Cut to Add at Peel Hunt; PT 85 pence
* Solwers Cut to Accumulate at Inderes; PT 4.20 euros
* Swatch Cut to Underweight at JPMorgan; PT 135 Swiss francs
* Vistry Group Cut to Underperform at RBC

>>> Initiation
* ABB Rated New Neutral at Grupo Santander; PT 52.10 Swiss francs (+)
* AF Gruppen Rated New Buy at Carnegie; PT 79 kroner (+)
* Cemex ADRs Reinstated Market Perform at BBVA; PT $6.80
* Dassault Aviation Reinstated Buy at Citi; PT 230 euros
* Pensionbee Group Rated New Buy at Canaccord; PT 217 pence (+)
* Schneider Electric Rated New Neutral at Grupo Santander (+)
* Siemens Reinstated Outperform at Grupo Santander (+)
* Sveafastigheter Rated New Buy at Nordea; PT 43 kronor
* Sveafastigheter Rated New Buy at SEB Equities; PT 44 kronor
* Sveafastigheter Rated New Buy at Kepler Cheuvreux; PT 43 kronor (+)
* Sveafastigheter Rated New Buy at DNB Markets; PT 47 kronor (++)
* Sveafastigheter Rated New Buy at Danske Bank Markets (++)

>>> Call
* Akzo, Air Liquide Upgraded at JPMorgan in 2025 Sector Preview
* Citi Reiterates BAE Buy Rating After BofA Downgrade Spurred Drop (++)
* Dassault Aviation’s Real Value is Being Masked, Citi Rates Buy
* JPMorgan Strategists See Smaller Caps Outperforming Next Year (++)
* Kering, Swatch Cut at JPMorgan on Tough Turnaround Environment
* Novo Raised at BNP Paribas Exane Ahead of CagriSema Results (+)
* Oddo BHF Strategists Say French Government Fall Isn’t Priced In (+)
* Primaris REIT Rated Outperform at RBC on ‘Unique’ Positioning (++)
* UK Housebuilders Oversold, Although Be ‘Discerning,’ RBC Says (+)
* ZURICH AIRPORT ADDED TO EUROPEAN CONVICTION LIST AT GOLDMAN (+)